BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Biontech Se Sponsored Adr (BNTX), Genmab (Otc) (GMAB) announced an update on their ongoing clinical study.

BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA ...

BioNTech’s messenger RNA technology led to a successful Covid-19 vaccine that provides it with plenty of cash for pipeline expansion. The company is deploying some of that capital in a new partnership ...

BioNTech recently announced it hosted its Innovation Series R&D Day on November 11, 2025, offering an in-depth update on its strategy and clinical pipeline via a public webcast, with replay and ...

Following suit with other companies that produce COVID-19 vaccines, BioNTech has discovered demand for its Pfizer-partnered, omicron-adapted shot has not met expectations this fall and has had to ...

People aiming to get its Comirnaty Covid vaccine won't need a doctor's prescription to do so. This was among several measures being considered by an advisory panel to the CDC. Investors were cheered ...

The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity. More than a few of those folks might not have realized that BioNTech owns and ...

Messenger RNA technology leaders Moderna and BioNTech have seen their stocks rally by around 75% and 150% respectively year-to-date driven by strong demand for their Covid-19 shots and also as ...

Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the ...

Moderna said Friday that it is suing Pfizer and BioNTech, alleging that the two companies copied Moderna's technology to make their Covid vaccine Comirnaty. "We believe that Pfizer and BioNTech ...

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...